×

Marrone Bio Innovations Submits Grandevo Bioinsecticide for Mexican Registration

Marrone Bio Innovations logo

DAVIS, Calif., April 17, 2014 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (Nasdaq:MBII), a leading global provider of bio-based pest management and plant health products announced it has submitted GRANDEVO® bioinsecticide for registration in Mexico. GRANDEVO controls a broad spectrum of insects and mites in a wide variety of agricultural crops. Upon registration, it will join REGALIA® MAXX biofungicide, the first MBI product registered in Mexico, in providing growers a high level of crop protection with the benefits of a bio-based product.

"Because of the large quantity of fruits and vegetables exported by Mexico, we believe GRANDEVO can satisfy a huge market need. The product is exempt from the maximum residue level (MRL) tolerances established for pesticides on food crops, so it is an ideal tool for helping growers avoid restrictions set by importing countries and regions like the U.S., Japan and the EU," explains Keith Pitts, MBI VP of Regulatory Affairs. He adds, "In addition, GRANDEVO can be applied right up to the day of harvest which is key to protect the appearance, quality, and market value of exported produce."

The active ingredient in GRANDEVO bioinsecticide is a microbe with insecticidal properties produced during the fermentation manufacturing process. GRANDEVO has multiple modes of action that makes the product an excellent addition to insect resistance management programs. This reduced risk of resistance is a real benefit in solving an increasing problem that hampers growers' ability to control crop-damaging pests. GRANDEVO—used alone or with synthetic insecticides, in rotation or in a tank mix—can help growers manage pests better and extend the useful life of other products.

The positive impact of this regulatory submission is summed up by Pitts, "The registration submission to Mexico of GRANDEVO is a very important step in making the benefits of the MBI line of biopesticides available to growers throughout Latin America and demonstrates the continued execution of our global revenue expansion strategy. REGALIA MAXX biofungicide is already being used in several countries in the region to help produce growers protect their export crops from diseases without pesticide residues and now this bioinsecticide will help some of these same growers protect their crops from destructive insects."

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (Nasdaq:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental, and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements relating to market size and the results from the field trials. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements, including the difficulty in predicting the outcome of product research and development efforts and regulatory approvals. Additional relevant information concerning risks can be found in the in the Form 10-K that the Company filed with the Securities and Exchange Commission on March 25, 2014.

CONTACT: Rich Fedigan Marrone Bio Innovations 530-750-8755 rfedigan@marronebio.com

Source:Marrone Bio Innovations